Owner Novagen Holding Corporation

Inventors Xu, Jing; Liu, Longbin; Du, Yong; Wang, Haitao; Zhang, Rui

Agent Davies Collison Cave

Pub. Number AU-B-2007209722

PCT Pub. Number WO2007/085084

Priority 11/340,661 27.01.06 US

Filing date 25 January 2007

Wipo publication date 2 August 2007

Acceptance publication date 26 July 2012

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 38/18 Medicinal preparations containing peptides - Growth factors

A61K 47/42 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/00 Drugs for disorders of the blood or the extracellular fluid

C07K 14/505 Peptides having more than 20 amino acids

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 Hybrid peptides

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12N 15/18 Mutation or genetic engineering

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione